Filing Details

Accession Number:
0000711377-13-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-08 17:36:10
Reporting Period:
2013-11-06
Filing Date:
2013-11-08
Accepted Time:
2013-11-08 17:36:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380814 Charles A. Fischer 620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-06 4,500 $11.14 9,000 No 4 M Direct
Common Stock Acquisiton 2013-11-06 4,500 $11.02 13,500 No 4 M Direct
Common Stock Acquisiton 2013-11-06 4,500 $13.56 18,000 No 4 M Direct
Common Stock Disposition 2013-11-06 13,500 $46.79 4,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2013-11-06 4,500 $0.00 4,500 $11.14
Common Stock Common Stock (Right to Buy) Disposition 2013-11-06 4,500 $0.00 4,500 $11.02
Common Stock Common Stock (Right to Buy) Disposition 2013-11-06 4,500 $0.00 4,500 $13.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,500 2017-10-11 No 4 M Direct
21,000 2018-10-10 No 4 M Direct
16,500 2019-10-09 No 4 M Direct
Footnotes
  1. Options were granted 10/11/2007 and vested in three years, with a ten year life
  2. Options were granted 10/10/2008, vested over three years and have ten year lives
  3. Options were granted 10/09/2009, vested over three years, and have ten year lives